SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,835,232 | -26.2% | 2,834,361 | -1.2% | 0.01% | -16.7% |
| Q2 2023 | $13,334,039 | +1.7% | 2,867,535 | +1.0% | 0.01% | -14.3% |
| Q1 2023 | $13,110,955 | -42.8% | 2,837,869 | -0.0% | 0.01% | -41.7% |
| Q4 2022 | $22,932,130 | +9.1% | 2,838,135 | -25.1% | 0.01% | +9.1% |
| Q3 2022 | $21,027,000 | +6.9% | 3,788,780 | +0.4% | 0.01% | +10.0% |
| Q2 2022 | $19,662,000 | -36.2% | 3,773,895 | +0.7% | 0.01% | -16.7% |
| Q1 2022 | $30,808,000 | -36.6% | 3,747,914 | +14.7% | 0.01% | -33.3% |
| Q4 2021 | $48,627,000 | -12.8% | 3,267,947 | +10.7% | 0.02% | -14.3% |
| Q3 2021 | $55,779,000 | +5.3% | 2,952,854 | +3.7% | 0.02% | +5.0% |
| Q2 2021 | $52,953,000 | -12.1% | 2,848,479 | +7.6% | 0.02% | -20.0% |
| Q1 2021 | $60,241,000 | +24.6% | 2,646,804 | +18.9% | 0.02% | +25.0% |
| Q4 2020 | $48,347,000 | – | 2,226,923 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |